OncoMatch/Clinical Trials/NCT07067268
Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy
Is NCT07067268 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies Adjuvant therapy for nasopharyngeal cancinoma (npc).
Treatment: Adjuvant therapy — This study aims to explore the efficacy and safety of tislelizumab combined with capecitabine in nasopharyngeal carcinoma patients with residual plasma EBV DNA after radiotherapy.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Head and Neck Squamous Cell Carcinoma
Performance status
ECOG 0–1(Restricted strenuous activity)
Prior therapy
Must have received: radiation therapy — definitive
Lab requirements
Blood counts
Hemoglobin ≥90 g/L; ANC ≥1.0×10⁹/L; Platelet count ≥80×10⁹/L
Kidney function
Serum creatinine ≤ULN, and creatinine clearance rate ≥50 mL/min (Cockcroft-Gault formula)
Liver function
Total bilirubin <1.5× ULN; ALT and AST <2.5× ULN
Cardiac function
Normal myocardial enzymes and thyroid function; Normal cardiac function assessed by echocardiography
Adequate organ function meeting the following criteria: Hematological: a. Hemoglobin (HB) ≥90 g/L; b. Absolute neutrophil count (ANC) ≥1.0×10⁹/L; c. Platelet count (PLT) ≥80×10⁹/L; Biochemical: a. Total bilirubin (BIL) <1.5× ULN; b. ALT and AST <2.5×ULN; c. Serum creatinine (Cr) ≤ULN, and creatinine clearance rate ≥50 mL/min (calculated by Cockcroft-Gault formula); d. Normal myocardial enzymes and thyroid function; e. Normal cardiac function assessed by echocardiography.
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07067268 currently recruiting?
Yes, this trial is currently recruiting patients.
Is prior treatment required for enrollment?
Yes. Patients must have previously received radiation therapy.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages